SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,901 | -49.0% | 143,656 | +2.6% | 0.00% | – |
| Q2 2023 | $670,595 | -81.1% | 139,999 | -77.6% | 0.00% | – |
| Q1 2023 | $3,539,000 | +103107.9% | 624,021 | +1.9% | 0.00% | – |
| Q4 2022 | $3,429 | -99.9% | 612,549 | -13.8% | 0.00% | -100.0% |
| Q3 2022 | $4,560,000 | +70.3% | 710,373 | -9.0% | 0.00% | – |
| Q2 2022 | $2,678,000 | +164.9% | 780,844 | +449.6% | 0.00% | – |
| Q1 2022 | $1,011,000 | +237.0% | 142,065 | +296.1% | 0.00% | – |
| Q4 2021 | $300,000 | -92.9% | 35,864 | -94.1% | 0.00% | -100.0% |
| Q3 2021 | $4,214,000 | +174.0% | 605,437 | +839.0% | 0.00% | – |
| Q2 2021 | $1,538,000 | -47.8% | 64,479 | -54.9% | 0.00% | – |
| Q1 2021 | $2,945,000 | -22.3% | 143,007 | -7.6% | 0.00% | -100.0% |
| Q4 2020 | $3,790,000 | -24.7% | 154,691 | -11.7% | 0.00% | 0.0% |
| Q3 2020 | $5,035,000 | +17.4% | 175,212 | -80.6% | 0.00% | 0.0% |
| Q2 2020 | $4,288,000 | +14.8% | 900,904 | -13.8% | 0.00% | 0.0% |
| Q1 2020 | $3,734,000 | +99.8% | 1,045,655 | +93.0% | 0.00% | – |
| Q4 2019 | $1,869,000 | -21.2% | 541,885 | -8.4% | 0.00% | – |
| Q3 2019 | $2,373,000 | +22.5% | 591,835 | -12.0% | 0.00% | – |
| Q2 2019 | $1,937,000 | -53.5% | 672,271 | +11.0% | 0.00% | -100.0% |
| Q1 2019 | $4,163,000 | +131.0% | 605,849 | +51.9% | 0.00% | – |
| Q4 2018 | $1,802,000 | -43.7% | 398,791 | -5.4% | 0.00% | -100.0% |
| Q3 2018 | $3,199,000 | -6.1% | 421,494 | +6.4% | 0.00% | 0.0% |
| Q2 2018 | $3,407,000 | +10.2% | 396,207 | -5.9% | 0.00% | 0.0% |
| Q1 2018 | $3,091,000 | -42.2% | 421,118 | -20.2% | 0.00% | 0.0% |
| Q4 2017 | $5,352,000 | -13.1% | 527,812 | +41.4% | 0.00% | 0.0% |
| Q3 2017 | $6,160,000 | +104.2% | 373,334 | +39.9% | 0.00% | 0.0% |
| Q2 2017 | $3,016,000 | -27.7% | 266,855 | -27.9% | 0.00% | 0.0% |
| Q1 2017 | $4,172,000 | +31.9% | 370,225 | +15.9% | 0.00% | 0.0% |
| Q4 2016 | $3,162,000 | +17.7% | 319,365 | +46.1% | 0.00% | 0.0% |
| Q3 2016 | $2,687,000 | -56.5% | 218,589 | +2.8% | 0.00% | -50.0% |
| Q2 2016 | $6,176,000 | +14.6% | 212,617 | +4.8% | 0.00% | +100.0% |
| Q1 2016 | $5,388,000 | -24.3% | 202,850 | -0.0% | 0.00% | -50.0% |
| Q4 2015 | $7,122,000 | +250.8% | 202,947 | +196.3% | 0.00% | +100.0% |
| Q3 2015 | $2,030,000 | +97.1% | 68,500 | +176.2% | 0.00% | – |
| Q2 2015 | $1,030,000 | – | 24,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
| ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
| Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
| Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
| Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
| FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
| Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
| A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |